HER2 Support Group Forums - View Single Post - New Phase II Trial of Combined Monoclonal Antibodies

Lori S · 08-07-2006, 06:33 PM

I just wanted to let you all know about this new clinical trial at NIH. The protocol # of the trial is 06-C-0035. The combined monoclonal antibodies are Trastuzumab (Herceptin) and Pertuzumab. I am currently enrolled in this trial and have received a total of 4 treatments to date. After two treatments my scans revealed a 6% reduction in my tumors within my lungs. The results from other patients enrolled in this trial after 2 treatments varied from no change to a 15% reduction. For me there have been no side effects at all.

To obtain more information about this trial please contact the research nurse Arlene Berman at 301-435-5609.

08-07-2006, 06:33 PM	#1
Lori S Member Join Date: Jan 2006 Location: Baldwin, Maryland Posts: 15	New Phase II Trial of Combined Monoclonal Antibodies I just wanted to let you all know about this new clinical trial at NIH. The protocol # of the trial is 06-C-0035. The combined monoclonal antibodies are Trastuzumab (Herceptin) and Pertuzumab. I am currently enrolled in this trial and have received a total of 4 treatments to date. After two treatments my scans revealed a 6% reduction in my tumors within my lungs. The results from other patients enrolled in this trial after 2 treatments varied from no change to a 15% reduction. For me there have been no side effects at all. To obtain more information about this trial please contact the research nurse Arlene Berman at 301-435-5609.